心連心化肥(01866.HK)鄭州研發中心揭幕
心連心化肥(01866.HK)宣布,旗下河南心連心化學工業集團的鄭州研發中心於6月18日舉行揭牌儀式。該中心主要包括化工品技術研究、科技成果轉化、新型肥料產品技術研究以及人才孵化等方向。
公司預期,研發中心將通過技術研究、項目論證及成果轉化等方式,與科研院所、高校進行合作對接,建立良好的「產、學、研」合作研究,提高科技創新能力,同時為未來發展儲備人才,增強公司核心競爭力。
董事長劉興旭表示,心連心鄭州研發中心將為提高公司核心競爭力提供有力技術保障,推動公司乃至行業的技術進步。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.